The FDA announced it will relax certain rules for approving low-cost versions of some high-priced medications.

One year of dual antiplatelet therapy with one of two potent P2Y12 inhibitors—ticagrelor or prasugrel—in people with Type 1 ...

One year of dual antiplatelet therapy with one of two potent P2Y12 inhibitors-ticagrelor or prasugrel-in people with Type 1 ...

Used to treat severely low blood sugar, glucagon can be a lifesaving medication for people with diabetes. Here’s how it works and when and how to use it.

In a large real-world analysis across three U.S. healthcare databases, semaglutide and tirzepatide showed cardiovascular benefits consistent with randomized trials. Semaglutide lowered heart attack ...